为什么现行指南不再建议老年人群常规服用阿司匹林来预防心脑血管事件?
Why do current guidelines no longer advise routine aspirin use in older adults to prevent cardiovascular events?
因为在老年人群中出血危害已经超过抗栓获益。阿司匹林不可逆乙酰化血小板环氧化酶-1,阻断血栓素A2合成而抑制聚集,确能减少缺血事件;但同一机制削弱胃肠黏膜保护并增加颅内出血风险。ASPREE等针对健康老年人的大型随机试验显示,常规服药并未显著降低首发心血管事件,严重出血反而增多,故指南转向个体化评估而非普遍推荐。
Because in older adults the bleeding harm now outweighs the antithrombotic benefit. Aspirin irreversibly acetylates platelet cyclooxygenase-1, blocking thromboxane A2 synthesis and aggregation; this curbs ischemic events but also erodes gastric mucosal protection and raises intracranial hemorrhage risk. Large randomized trials in healthy elders such as ASPREE found no significant reduction in first cardiovascular events while severe bleeding increased, so guidelines shifted to individualized assessment instead of routine recommendation.
难度 专业 · 适合 高中(15-18)
CC BY 4.0 · 已核验 · Verified 2026-11-03
来源 · Source
McNeil JJ等论文《Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly》(ASPREE研究),New England Journal of Medicine 2018(莫纳什大学等)
McNeil JJ et al., 'Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly' (ASPREE trial), New England Journal of Medicine, 2018 (Monash University and collaborators)
独立核验依据 · Independent verification: 核验依据 1 EUROPEPMC 标识 30221597：Effect of Aspirin on Cardiovascula
#阿司匹林 #一级预防 #出血风险
CANTOS试验中,卡纳单抗为何能在不降低LDL胆固醇的情况下减少心血管事件的复发?
In the CANTOS trial, why did canakinumab lower the rate of recurrent cardiovascular events without reducing LDL cholesterol?
这说明血管炎症本身是动脉粥样硬化的独立干预靶点,降脂并非唯一路径。IL-1β经斑块内NLRP3炎症小体激活后释放,维持慢性血管炎症并使斑块易损;卡纳单抗阻断该通路后,高敏C反应蛋白显著下降,复合终点事件明显减少,而血脂水平保持不变。CANTOS为炎症假说提供了人体级证据,也推动了心肌梗死后残余炎症风险评估的发展。
It demonstrated that vascular inflammation is an independent therapeutic target in atherosclerosis, with lipid lowering not the only route. Interleukin-1 beta is released upon NLRP3 inflammasome activation inside plaques, sustaining chronic vascular inflammation and making plaques vulnerable. Blocking this pathway markedly lowered high-sensitivity CRP and reduced the composite endpoint while cholesterol remained unchanged. CANTOS delivered human evidence for the inflammation hypothesis and spurred assessment of residual inflammatory risk after myocardial infarction.
难度 专业 · 适合 小学高段(9-12)
CC BY 4.0 · 已核验 · Verified 2026-11-03
来源 · Source
Ridker PM等论文《Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease》,New England Journal of Medicine 2017(CANTOS研究)
Ridker PM et al., Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease (CANTOS), New England Journal of Medicine 2017
独立核验依据 · Independent verification: 核验依据 1 EUROPEPMC 标识 28845751：Antiinflammatory Therapy with Cana
#炎症 #动脉粥样硬化 #白介素-1β
他汀类药物用于心血管疾病一级预防时,主要通过什么机制降低心梗与卒中的发生风险?
When statins are used for primary prevention of cardiovascular disease, what is the main mechanism by which they lower the risk of heart attack and stroke?
主要靠大幅降低血液低密度脂蛋白胆固醇(LDL-C)以延缓动脉粥样硬化进程。他汀抑制肝脏HMG-CoA还原酶,肝细胞内胆固醇合成减少,膜上LDL受体代偿性上调,加速清除血浆LDL颗粒;斑块脂核缩小、纤维帽趋稳,破裂继发血栓的概率随之下降。JUPITER等试验证实,尚无心肌梗死或卒中史的高危人群服他汀后首次重大血管事件也显著减少。
Mainly by sharply lowering LDL cholesterol and slowing atherosclerosis. Statins inhibit hepatic HMG-CoA reductase; reduced intracellular cholesterol drives compensatory up-regulation of LDL receptors that clear plasma LDL particles. Plaque lipid cores shrink and fibrous caps stabilize, making rupture and thrombosis less likely. Trials such as JUPITER showed significantly fewer first major vascular events even in high-risk people without prior heart attack or stroke.
难度 进阶 · 适合 初中(12-15)
CC BY 4.0 · 已核验 · Verified 2026-11-03
来源 · Source
Ridker PM等论文《Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein》(JUPITER研究),New England Journal of Medicine 2008(布莱根妇女医院)
Ridker PM et al., 'Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein' (JUPITER trial), New England Journal of Medicine, 2008 (Brigham and Women's Hospital)
独立核验依据 · Independent verification: 核验依据 1 CROSSREF 标识 10.1016/s0749-4041(08)79103-6：Rosuvastatin t
#他汀 #一级预防 #动脉粥样硬化
SPRINT研究发现,将高危患者的收缩压强化控制在120毫米汞柱目标以下,为什么能显著减少心血管事件?
Why did targeting systolic blood pressure below 120 mmHg significantly reduce cardiovascular events among high-risk patients in the SPRINT trial?
关键在于把血压降得更低,动脉壁承受的机械应力随之减小。持续高压加速血管内皮损伤与动脉粥样硬化斑块进展,并促成左心室肥厚。强化降压组主要心血管事件比标准组下降约四分之一,全因死亡率降低近三成。机理上,较低的压力负荷减轻血流剪切对内皮的损害,延缓小动脉重塑,促进左心室肥厚逆转,从而减少心梗、卒中和心力衰竭。
The decisive factor is that a lower systolic load exposes the arterial walls to less mechanical stress. Sustained hypertension accelerates endothelial injury, atherosclerotic plaque progression and left ventricular hypertrophy. In the intensive group the primary cardiovascular outcome fell by about a quarter and all-cause mortality by nearly thirty percent versus standard care. Mechanistically, reduced pressure lessens hemodynamic injury to the endothelium, slows small-artery remodeling and favors regression of left ventricular hypertrophy, cutting myocardial infarction, stroke and heart failure.
难度 进阶 · 适合 初中(12-15)
CC BY 4.0 · 已核验 · Verified 2026-11-04
来源 · Source
The SPRINT Research Group,《A Randomized Trial of Intensive versus Standard Blood-Pressure Control》,New England Journal of Medicine,2015 (DOI: 10.1056/nejmoa1511939)
The SPRINT Research Group, 'A Randomized Trial of Intensive versus Standard Blood-Pressure Control', New England Journal of Medicine, 2015, DOI: 10.1056/nejmoa1511939
独立核验依据 · Independent verification: 核验依据 1 Crossref DOI 10.1056/nejmoa1511939
#高血压 #强化降压 #心血管预后
有些患者危险因素评分很高，但冠脉CT显示钙化积分为零，为什么指南允许推迟启动他汀？
Why can clinicians defer statin therapy when a patient's risk factors look ominous but the coronary artery calcium score turns out to be zero?
钙化为零提示动脉里几乎没有亚临床粥样斑块，近期事件风险远低于仅凭危险因素估计的水平。危险因素只是概率性输入，钙化积分则直接量化了多年暴露累积形成的真实斑块负荷，MESA研究证实零积分人群十年事件率极低。因此影像结果可用于风险再分层，把名义上的高危者下调为低危，指南据此支持暂缓他汀，并在随访复查后再作决定。
A zero score signals essentially no subclinical atherosclerotic plaque, placing near-term event risk far below what risk factors alone predict. Risk factors are probabilistic inputs, whereas the calcium score directly quantifies the true plaque burden accumulated over years of exposure; MESA confirmed that people with a zero score have extremely low ten-year event rates. Imaging therefore reclassifies nominally high-risk patients downward, letting guidelines justify holding statins until follow-up scanning informs the decision.
难度 进阶 · 适合 初中(12-15)
CC BY 4.0 · 来源待核验 · Source pending review
来源 · Source
出处备注：著录含书名，但缺版次 / 出版社 / 年份中的一部分，需编辑补全后才能做独立比对。
Detrano R等论文《Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups》（MESA研究），New England Journal of Medicine 2008年，NHLBI资助
Detrano R et al., Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups (MESA), New England Journal of Medicine 2008, funded by NHLBI
独立核验依据 · Independent verification: 核验依据 1 CROSSREF 标识 10.1016/s0098-1672(08)79200-2：Coronary Calci · 核验依据 3 Crossref DOI 10.1056/nejmoa072100
#冠脉钙化积分 #风险再分层 #一级预防